[HTML][HTML] Peptide-based agents for cancer treatment: current applications and future directions

NTT Nhàn, T Yamada, KH Yamada - International Journal of Molecular …, 2023 - mdpi.com
Peptide-based strategies have received an enormous amount of attention because of their
specificity and applicability. Their specificity and tumor-targeting ability are applied to …

[HTML][HTML] Gastrinoma

RT Jensen, T Ito - Endotext [Internet], 2023 - ncbi.nlm.nih.gov
Gastrinomas are neuroendocrine neoplasms (NENs), that occur primarily in the duodenum
and pancreas, which ectopically secrete gastrin, resulting in the Zollinger-Ellison syndrome …

[HTML][HTML] Recurrence-Free Survival and Disease-Specific Survival in Patients with Pancreatic Neuroendocrine Neoplasms: A Single-Center Retrospective Study of 413 …

S Møller, SW Langer, C Slott, J Krogh, CP Hansen… - Cancers, 2023 - mdpi.com
Simple Summary The survival and disease recurrence for pancreatic neuroendocrine
tumors differs greatly. The aim of our retrospective study was to investigate prognostic …

[HTML][HTML] Lung NETs and GEPNETs: One Cancer with Different Origins or Two Distinct Cancers?

G Evangelou, I Vamvakaris, A Papafili, M Anagnostakis… - Cancers, 2024 - mdpi.com
Simple Summary This review examined the disparities between lung neuroendocrine
tumors and gastroentero-pancreatic neuroendocrine tumors, two types of neuroendocrine …

[HTML][HTML] Neuroendocrine Neoplasia: From Pathophysiology to Novel Therapeutic Approaches

M Carsote, C Nistor - Biomedicines, 2024 - mdpi.com
Neuroendocrine neoplasia (NEN) represents a sensational field of modern medicine;
immense progress in emerging biochemical, molecular, endocrine, immunohistochemical …

[HTML][HTML] Pathological complete response of initially unresectable multiple liver metastases achieved using combined peptide receptor radionuclide therapy and …

R Umino, S Nara, N Kobayashi, T Mizui… - Surgical Case …, 2024 - Springer
Background Peptide receptor radionuclide therapy (PRRT) serves as a novel and effective
treatment option for somatostatin receptor-positive unresectable liver metastases of …

[HTML][HTML] Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis

Y Yan, D Wu, W Wang, Y Lv, L Yang, Y Liu… - Journal of Cancer …, 2024 - journals.lww.com
Objective: To determine the effectiveness and safety of neoadjuvant therapy in
gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) and provide evidence …

[HTML][HTML] Targeted Nuclear Medicine. Achievements, Challenges and Prospects

MV Kovalchuk, SM Deyev, KA Sergunova - Nanobiotechnology Reports, 2023 - Springer
The path of the development of nuclear medicine at the international level and that in Russia
is presented. Significant achievements in the development and establishment of nuclear …

Identification of Wandering Masses and Tumor Heterogeneity on 68Ga-DOTATATE and 18F-FDG PET/CT in Metastatic Grade II Neuroendocrine Tumor with Increased …

P Baberwal, R Parghane, S Basu - Journal of Nuclear Medicine …, 2024 - Soc Nuclear Med
Neuroendocrine tumors (NETs) may manifest as large masses in the abdominopelvic region
that exhibit mobility and shifting, potentially leading to diagnostic uncertainty both before and …

Таргетная ядерная медицина. Достижения, проблемы и перспективы

МВ Ковальчук, СМ Деев, КА Сергунова - Российские нанотехнологии, 2023 - elibrary.ru
Представлен путь развития ядерной медицины на международном и отечественном
уровнях. Представлены значимые достижения в развитии и становлении ядерно …